Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | 15 | 0 | 2 | 0 | €27.01 | €36.17 | 33.929% |
| Celldex Therapeutics | 15 | 1 | 3 | 0 | €33.60 | €58.01 | 72.651% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €40.40 | €46.08 | 14.066% |
| Geron Corp. | 16 | 0 | 2 | 0 | €4.19 | €5.57 | 32.984% |
| PTC Therapeutics Inc. | 16 | 9 | 2 | 1 | €28.80 | €41.81 | 45.188% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €177.60 | €182.79 | 2.922% |
| Esperion Therapeutis.Inc. | 17 | 2 | 3 | 2 | €2.26 | €8.39 | 271.729% |
| Exelixis Inc. | 19 | 0 | 1 | 0 | €20.42 | €26.01 | 27.357% |
| Exact Sciences | 19 | 0 | 5 | 0 | €41.44 | €75.00 | 80.997% |
| Halozyme Therapeutics Inc. | 20 | 0 | 2 | 0 | €48.44 | €52.75 | 8.893% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 1 | 0 | €77.02 | €103.66 | 34.586% |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 0 | 0 | €43.51 | €56.72 | 30.365% |
| Abbott Laboratories | 21 | 0 | 3 | 0 | €94.88 | €115.05 | 21.258% |
| G1 Therapeutics | 21 | 2 | 3 | 1 | €2.38 | €8.39 | 253.106% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 5 | 0 | €23.81 | €54.94 | 130.739% |
| TG Therapeutics Inc. | 22 | 3 | 0 | 0 | €17.96 | €28.06 | 56.279% |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 3 | 0 | €7.84 | €27.83 | 255.168% |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 1 | 0 | €37.40 | €85.51 | 128.640% |
| United Therapeutics | 22 | 0 | 3 | 0 | €292.60 | €289.92 | -0.916% |
| Gilead Sciences Inc | 23 | 1 | 12 | 0 | €62.58 | €75.00 | 19.847% |
| Zoetis Inc. A | 24 | 1 | 1 | 0 | €162.74 | €198.11 | 21.735% |
| Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | €15.10 | €31.00 | 105.389% |
| Neurocrine Bioscience | 33 | 0 | 2 | 0 | €130.75 | €140.87 | 7.738% |